<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font20">the </span>
   <span class="font16">cells </span>
   <span class="font15">CMV </span>
   <span class="font15">al., </span>
   <span class="font15">with </span>
   <span class="font13">for </span>
   <span class="font13">responses </span>
   <span class="font13">:â€". </span>
   <span class="font13">were </span>
   <span class="font13">was </span>
   <span class="font12">cell </span>
   <span class="font12">vaccine </span>
   <span class="font12">Senegalese </span>
   <span class="font11">associated </span>
   <span class="font11">{background </span>
   <span class="font11">adults </span>
   <span class="font11">The </span>
   <span class="font11">CMVâˆ’ </span>
   <span class="font11">are </span>
   <span class="font11">review </span>
   <span class="font11">Ebola </span>
   <span class="font11">young </span>
   <span class="font11">&amp;amp; </span>
   <span class="font11">(Fig. </span>
   <span class="font11">Immunol. </span>
   <span class="font11">have </span>
   <span class="font11">immune </span>
   <span class="font11">margin </span>
   <span class="font11">participants </span>
   <span class="font11">memory </span>
   <span class="font11">reduced </span>
   <span class="font11">that </span>
   <span class="font11">{border-style </span>
   <span class="font11">CDKLRG </span>
   <span class="font11">infection </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">between </span>
   <span class="font10">conducted </span>
   <span class="font10">human </span>
   <span class="font10">from </span>
   <span class="font10">these </span>
   <span class="font10">within </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">each </span>
   <span class="font10">increased </span>
   <span class="font10">individuals </span>
   <span class="font10">populations </span>
   <span class="font10">all </span>
   <span class="font10">also </span>
   <span class="font10">both </span>
   <span class="font10">study </span>
   <span class="font10">vaccination </span>
   <span class="font10">van </span>
   <span class="font10">analysis </span>
   <span class="font10">antibody </span>
   <span class="font10">been </span>
   <span class="font10">cohort </span>
   <span class="font10">cytomegalovirus </span>
   <span class="font10">expansion </span>
   <span class="font10">response </span>
   <span class="font10">this </span>
   <span class="font10">Research </span>
   <span class="font10">eBioscience), </span>
   <span class="font10">editingWriting </span>
   <span class="font10">expanded </span>
   <span class="font10">healthy </span>
   <span class="font10">markers </span>
   <span class="font10">vaccine-specific </span>
   <span class="font10">Virol. </span>
   <span class="font10">cells, </span>
   <span class="font10">effector </span>
   <span class="font10">expression </span>
   <span class="font10">had </span>
   <span class="font10">low </span>
   <span class="font10">not </span>
   <span class="font10">shown </span>
   <span class="font10">using </span>
   <span class="font10">volunteers </span>
   <span class="font10">Cells </span>
   <span class="font10">Infect. </span>
   <span class="font10">Oxford </span>
   <span class="font10">clinical </span>
   <span class="font10">differentiated </span>
   <span class="font10">individuals. </span>
   <span class="font10">previously </span>
   <span class="font10">seroprevalence </span>
   <span class="font10">studies </span>
   <span class="font10">trial </span>
   <span class="font10">virus </span>
   <span class="font10">BioLegend), </span>
   <span class="font10">CMV, </span>
   <span class="font10">Dis. </span>
   <span class="font10">However, </span>
   <span class="font10">IFN-Î³ </span>
   <span class="font10">KLRG </span>
   <span class="font10">Med. </span>
   <span class="font10">Senegal, </span>
   <span class="font10">cohorts </span>
   <span class="font10">different </span>
   <span class="font10">elderly </span>
   <span class="font10">frequencies </span>
   <span class="font10">impact </span>
   <span class="font10">px; </span>
   <span class="font10">reduction </span>
   <span class="font10">study. </span>
   <span class="font10">used </span>
   <span class="font10">which </span>
   <span class="font10">{font-family </span>
   <span class="font10">(D) </span>
   <span class="font10">Clinical </span>
   <span class="font10">Dunnâ€™s </span>
   <span class="font10">ELISA </span>
   <span class="font10">Figure </span>
   <span class="font10">Frequency </span>
   <span class="font10">IgG </span>
   <span class="font10">Kruskalâ€"Wallis </span>
   <span class="font10">PBMCs </span>
   <span class="font10">T-cell </span>
   <span class="font10">University </span>
   <span class="font10">against </span>
   <span class="font10">assessed </span>
   <span class="font10">compared </span>
   <span class="font10">den </span>
   <span class="font10">developing </span>
   <span class="font10">express </span>
   <span class="font10">font-size </span>
   <span class="font10">frequency </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">measured </span>
   <span class="font10">positive </span>
   <span class="font10">seropositive </span>
   <span class="font10">significant </span>
   <span class="font10">significantly </span>
   <span class="font10">such </span>
   <span class="font10">trials </span>
   <span class="font10">â€" </span>
   <span class="font10">Although </span>
   <span class="font10">CD:CD </span>
   <span class="font10">CDâˆ’CDâˆ’ </span>
   <span class="font10">CMVâˆ’, </span>
   <span class="font10">IQRs. </span>
   <span class="font10">Medians </span>
   <span class="font10">Multiplex </span>
   <span class="font10">Rev. </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">Vaccine. </span>
   <span class="font10">after </span>
   <span class="font10">antigen </span>
   <span class="font10">based </span>
   <span class="font10">bead </span>
   <span class="font10">double; </span>
   <span class="font10">effect </span>
   <span class="font10">exposure </span>
   <span class="font10">expressing </span>
   <span class="font10">has </span>
   <span class="font10">hepatitis </span>
   <span class="font10">individuals, </span>
   <span class="font10">influenza </span>
   <span class="font10">negatively </span>
   <span class="font10">novel </span>
   <span class="font10">number </span>
   <span class="font10">other </span>
   <span class="font10">our </span>
   <span class="font10">post-test </span>
   <span class="font10">production </span>
   <span class="font10">proportions </span>
   <span class="font10">role </span>
   <span class="font10">row) </span>
   <span class="font10">serum </span>
   <span class="font10">some </span>
   <span class="font10">subsets </span>
   <span class="font10">terminally </span>
   <span class="font10">there </span>
   <span class="font10">total </span>
   <span class="font10">two </span>
   <span class="font10">(C) </span>
   <span class="font10">Bowyer </span>
   <span class="font10">CDâˆ’CDâˆ’CD </span>
   <span class="font10">Fig. </span>
   <span class="font10">MVAâ€"EBO-Z </span>
   <span class="font10">One. </span>
   <span class="font10">PLoS </span>
   <span class="font10">WaterboerT., </span>
   <span class="font10">Zaire </span>
   <span class="font10">across </span>
   <span class="font10">adults. </span>
   <span class="font10">aged </span>
   <span class="font10">analyses. </span>
   <span class="font10">association </span>
   <span class="font10">bars </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">but </span>
   <span class="font10">changes </span>
   <span class="font10">cohort. </span>
   <span class="font10">comparable </span>
   <span class="font10">comparison </span>
   <span class="font10">cytokine </span>
   <span class="font10">described </span>
   <span class="font10">e./journal.pone. </span>
   <span class="font10">flow </span>
   <span class="font10">highly </span>
   <span class="font10">indicate </span>
   <span class="font10">may </span>
   <span class="font10">over </span>
   <span class="font10">pathogen </span>
   <span class="font10">pathogens </span>
   <span class="font10">peripheral </span>
   <span class="font10">population </span>
   <span class="font10">proliferative </span>
   <span class="font10">proportion </span>
   <span class="font10">ratio </span>
   <span class="font10">receptor </span>
   <span class="font10">senescence </span>
   <span class="font10">senescent </span>
   <span class="font10">seropositivity </span>
   <span class="font10">solid; </span>
   <span class="font10">standard </span>
   <span class="font10">than </span>
   <span class="font10">type </span>
   <span class="font10">units </span>
   <span class="font10">while </span>
   <span class="font10">yr) </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(B) </span>
   <span class="font10">(E) </span>
   <span class="font10">(RPA-T, </span>
   <span class="font10">(Ref: </span>
   <span class="font10">(Venkatraman </span>
   <span class="font10">(bottom </span>
   <span class="font10">(top </span>
   <span class="font10">**, </span>
   <span class="font10">.). </span>
   <span class="font10">./jimmunol... </span>
   <span class="font10">All </span>
   <span class="font10">Antibody </span>
   <span class="font10">C). </span>
   <span class="font10">CMV-specific </span>
   <span class="font10">Cell </span>
   <span class="font10">ChAdâ€"EBO-Z </span>
   <span class="font10">ELISPOT </span>
   <span class="font10">Error </span>
   <span class="font10">Exp. </span>
   <span class="font10">GPâ€"specific </span>
   <span class="font10">JohanssonB., </span>
   <span class="font10">KlenermanP., </span>
   <span class="font10">Mannâ€"Whitney </span>
   <span class="font10">MichelA., </span>
   <span class="font10">National </span>
   <span class="font10">Oxford, </span>
   <span class="font10">Sci. </span>
   <span class="font10">Senegal </span>
   <span class="font10">Swedish </span>
   <span class="font10">Vaccine </span>
   <span class="font10">WikbyA., </span>
   <span class="font10">adults.(A) </span>
   <span class="font10">although </span>
   <span class="font10">analyses </span>
   <span class="font10">antibodies </span>
   <span class="font10">antigen-specific </span>
   <span class="font10">antigens </span>
   <span class="font10">assay </span>
   <span class="font10">baseline </span>
   <span class="font10">bold </span>
   <span class="font10">carriage </span>
   <span class="font10">cells. </span>
   <span class="font10">children </span>
   <span class="font10">cholera </span>
   <span class="font10">chronic </span>
   <span class="font10">column </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">developed </span>
   <span class="font10">differences </span>
   <span class="font10">differentiation </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">following </span>
   <span class="font10">graphs. </span>
   <span class="font10">groups. </span>
   <span class="font10">immunosenescence </span>
   <span class="font10">infected </span>
   <span class="font10">infections </span>
   <span class="font10">into </span>
   <span class="font10">killer </span>
   <span class="font10">lower </span>
   <span class="font10">manuscript. </span>
   <span class="font10">marked </span>
   <span class="font10">median </span>
   <span class="font10">observed </span>
   <span class="font10">old </span>
   <span class="font10">one </span>
   <span class="font10">participants. </span>
   <span class="font10">peak </span>
   <span class="font10">per </span>
   <span class="font10">phenotyping </span>
   <span class="font10">primary </span>
   <span class="font10">pt;} </span>
   <span class="font10">repertoire </span>
   <span class="font10">responses. </span>
   <span class="font10">results </span>
   <span class="font10">risk </span>
   <span class="font10">same </span>
   <span class="font10">serology </span>
   <span class="font10">stimulated </span>
   <span class="font10">strategy </span>
   <span class="font10">subset </span>
   <span class="font10">terminal </span>
   <span class="font10">then </span>
   <span class="font10">they </span>
   <span class="font10">very </span>
   <span class="font10">viral </span>
   <span class="font10">virus; </span>
   <span class="font10">well </span>
   <span class="font10">when </span>
   <span class="font10">younger </span>
  </p>
 </body>
</html>
